Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Jill P Smith

2297: Dietary fat stimulates growth of pancreatic cancer growth through the cholecystokinin receptor

scientific article published in September 2017

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma

scientific article

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

scientific article published on 11 July 2019

A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer

scientific article published on 09 January 2020

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

scientific article published in February 2012

Amantadine therapy for chronic hepatitis C: a dose escalation study

scientific article

Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo

scientific article

Calcium phosphosilicate nanoparticles for imaging and photodynamic therapy of cancer

scientific article published on April 2012

Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues

scientific article published on 20 June 2017

Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.

scientific article

Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis

scientific article published on 09 October 2019

Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer

scientific article published on 7 March 2018

Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.

scientific article

Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice

scientific article published on 17 October 2017

Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice

scientific article

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

scientific article

Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor

scientific article published on 21 June 2018

Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival

scientific article

Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis

scientific article

Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer

scientific article published on 30 June 2017

Endogenous Gastrin Collaborates With Mutant KRAS in Pancreatic Carcinogenesis

scientific article published on 01 August 2019

Gaps and Opportunities in Pancreatic Disease Research ⬇️

scientific article published on May 1, 2013

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer

scientific article published on 01 December 2021

Gastrin and Gastric Cancer

scientific article published on 14 March 2017

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment

scientific article published on 24 September 2019

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

scientific article published on 8 February 2018

Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer.

scientific article published on 7 January 2016

Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression

scientific article published on July 2009

Low-dose naltrexone therapy improves active Crohn's disease

scientific article

Novel strategies for managing pancreatic cancer.

scientific article

Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer ⬇️

scientific article published on March 1, 2010

Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop

scientific article

PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate

scientific article published on 14 February 2013

Role of endogenous cholecystokinin on growth of human pancreatic cancer.

scientific article published on 24 December 2010

Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer

scientific article published on 28 October 2020

The opioid antagonist naltrexone improves murine inflammatory bowel disease

scientific article

Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's Patients ⬇️

scientific article published on April 18, 2013

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial

scientific article

Treatment of advanced pancreatic cancer with opioid growth factor: phase I.

scientific article

Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases

scientific article published on 21 August 2019

Paulina is supported by:

About Paulina

Help